10-QFiling Date: Aug 4, 2026
Edwards Lifesciences (EW)
ew-20260630
View SEC Filing
ACC: 0001099800-26-000043
Key Financial MetricsFY2026 · 2026-06-30
Revenue$1.74B
Net Income$241.9M
Total Assets$13.87B
Stockholders' Equity$10.62B
Operating Cash Flow$695.7M